Search
News
Drug & Medical Device & Aesthetics, 肌顏態 was displayed at the CSD2025, The GeneQueens and 金因敷 launch was grandly held in Changsha
On June 27, 2025, Uni-Bio Science Group Limited (the “Group”)grandly held a new medical aesthetics product launch event in Changsha, releasing the high-end series GeneQueens of 肌顏態® and the medical device brand 金因敷®. Many experts, KOLs and partners attended the event. This launch not only showcased the Group's achievements in R&D, but also marked the comprehensive layout in the "drug, medical device and Aesthetics" field. （Photo: : group photo at the launch ）High-end medical aesthetics: GeneQueens seriesAt the launch, the Group unveiled the high-end series of 肌顏態® -——GeneQueensTM (Human-Sequence Triple Protein Repair & Balance Ampoule). which functions on skin repair and anti-aging. By activating cell regeneration, it helps users restore their youthful and healthy skin condition.（Photo: GeneQueens product image）GeneQueensTM sets a new standard for anti-aging and repair by adding three core ingredients in sufficient quantities. Skbrella FN, as a key ingredient for cell repair, can accelerate the healing of skin wounds and promote the adhesion and migration of new cells. III Collagen strongly fills the skin structure, significantly enhancing elasticity and firmness. XVII Collagen can strengthen the connection between the epidermis and dermis, and consolidate the youthful foundation of the skin.In addition, GeneQueens adopts a sterile and preservative-free formula, relying on high-purity raw materials and patented technology, providing users with an "instant enjoyment" precise and efficient experience. Its unique formula and outstanding efficacy were highly recognized by many experts on the spot.2、金因敷 showcased a variety of new productsMeanwhile, the Group also launched several new products of its medical device brand - 金因敷®, focusing on the professional repair field of medical aesthetics.（Photo: 金因敷 series product picture）金因敷® complies with strict clinical trials and quality inspections to ensure its safety and effectiveness. The product adopts a high-purity non-allergenic formula, which can moisturize and accelerate wound repair. It also uses an exclusive cooling technology to relieve postoperative swelling and pain, providing a professional solution for sensitive skin and post-medical procedure care.3、The latest research data was presented at CSD2025It is worth mentioning that 肌顏態® also showcased the research data of "The Efficacy Study of Fibronectin in the Repair of Skin Barrier Damage for the post-medical procedure" jointly conducted with the Cosmetics Testing Center of the Dermatology Hospital of Southern Medical University in the poster area of the 30th Academic Conference of the Chinese Medical Association (CSD2025). This is not only an endorsement of the Group's research capabilities, but also provides experts and scholars in the industry with an opportunity to gain a deeper understanding of the 肌顏態® technology and products.As an annual grand event in the field of dermatology and venereology in China, CSD2025 brings together authoritative experts and scholars in dermatology across the country, presenting multi-dimensional academic achievements and exchanges of ideas. The poster area is one of the core venues of the academic annual conference. Posters are not only an important way for researchers to showcase their scientific research achievements, but also a key link in promotingthe dissemination of academic ideas and the feedback of clinical practice.（Photo: The research poster of 肌顏態 at the CSD 2025）4、Academic speeches by several expertsSeveral clinical experts at the launch further recognized thesignificant clinical valueof 肌顏態® and 金因敷®. The experts highlighted that 肌顏態®’ spatented ingredient, Skbrella FN,demonstrates immense potentialin improving damaged sensitive skin barriers, reducing inflammatory erythema, alleviating discomfort sensationssuch as burning, tightness and itching, as well as enhancing post-laser repair and healing.In the clinical observations over the past few months, many patients treated with 肌顏態® have achieved remarkable therapeutic effects. The symptoms of anesthetic allergy have been rapidly relieved, the inflammatory pigmentation post-laser has significantly improved, the skin barrier has been repaired, and the patient satisfaction rate is extremely high. 金因敷® can effectively reduce redness, swelling and pain for post-medical procedures, accelerate wound healing and shorten the recovery time.(Photo 1: 肌顏態 use case sharing by Professor Shi Ge, Director of the Department of Plastic Surgery of the Sixth Affiliated Hospital of Sun Yat-sen University)(Photo 2: 肌顏態 use case sharing by Professor Ge Lan, from The First Affiliated Hospital of Army Medical University)(Photo 3: Fibronectin clinical trial results sharing by Professor Ye Li, Head of Cosmetics Testing Center at Dermatology Hospital of Southern Medical University)(Photo 4: Mr. Du Wei, CEO of Cosmetics News & Cosmetics Business Online, analyzes cosmetics industry development trends)6、The signing ceremony reflects the market potentialMr. Zhao Zhigang, CEO of Uni-Bio Science Group, emphasized:" We have always adhered to the standards of biopharmaceuticals in creating skin care products. The release of GeneQueens and 金因敷 is an important milestone in building the "Drugs, Medical device and Aesthetics" strategy and creating a full-cycle skin care solution, aiming to meet consumers' increasingly refined skin health needs. "(Photo: Mr. Zhao Zhigang, CEO of Uni-Bio Science Group, addressing the launch event.)Furthermore,Ms. Liu Yihua, President of Global Cosmetics Group, attended the launch as an important guest. Uni-Bio Science Group and Global Cosmetics Group havejointly established a medical research co-creation biological platform. Utilizinggene-editing biosynthesis technology, the platform has launched Skbrella FN – ahighly bioactive recombinant human fibronectinknown as "皮優理".The launch also witnessed a grand strategic signing ceremony. The Group has achieved in-depth cooperation with many well-known medical aesthetics chain institutions and well-known agents. This signing is not only a high recognition of the quality and market potential of GeneQueens and 金因敷®, but also a key step for the Group to accelerate commercialization and expand channels. Through strong alliances with leading channel partners, the Group will reach the core consumers and ensure the rapid release of huge commercial value.(Photo: Group photo of the strategic signing ceremony)The successful holding of this launch not only marks a crucial step for the Group in medical aesthetics and medical devices, but also demonstrates the Group's in-depth layout and forward-looking vision in the "Drugs, Medical device and Aesthetics" strategy. In the future, the Group will continue to be guided by technology and oriented towards clinical value, accelerate product innovation and technological upgrading, constantly enrich pipeline, and meet the growing market demands.About Uni-Bio Science GroupUni-Bio Science Group Limited is principally engaged in the research and development, manufacture and sales of pharmaceutical products. The research and development center is fully equipped with a complete system for the development of genetically-engineered products with a pilot plant test base which is in line with NMPA requirements. The Group also has three GMP manufacturing bases in Beijing, Dongguan and Shenzhen. The Group also has a highly efficient commercialization platform and marketing network. The Group focuses on the development of novel treatments and innovative drugs addressing the therapeutic areas of endocrine such as diabetes and osteoporosis, ophthalmology and dermatology. Uni-Bio Science Group Limited was listed on the Main Board of the Hong Kong Stock Exchange on November 12, 2001. Stock code: 0690.End02/07/2025 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.comEQS
Jul 2, 2025
24H｜Gryphon Digital Mining Soars 64%; Constellation Brands Drops 1%; Centene Tumbles 24%
Gryphon Digital Mining shares soared 64.2% in overnight trading. American Bitcoin Corp. and Gryphon Digital Mining have filed an amended registration statement on Form S-4 with the SEC for their planned stock-for-stock merger, according to a press release statement issued Tuesday. American Bitcoin, ...Tiger News
Jul 2, 2025
Post-Bell | Dow Rises 0.9%; Tesla Sinks 5%; Nvidia and Meta Drop 3%; Sunrun Jumps 11%; Wolfspeed Soars 98%
The Nasdaq and the S&P 500 closed lower on Tuesday, dragged down by weakness in large-cap tech stocks, while the Dow ended higher in a volatile day marked by seasonally low liquidity.Market SnapshotDow Jones Industrial Average rose 400.17 points, or 0.91%, to 44,494.94. The S&P 500 lost 6.94 points,...Tiger News
Jul 1, 2025
Top Calls on Wall Street: Nvidia, Tesla, Amazon, Meta, Hasbro, Boeing, Robinhood & More
Here are the biggest calls on Wall Street on Tuesday:Goldman Sachs upgrades Hasbro to buy from neutralGoldman says it sees upside to consensus for the toy company.“We upgrade shares of Hasbro (HAS) to Buy (from Neutral) and increase our Price Target to $85 ($66 prior), representing 21% total potenti...Tiger News
Jul 1, 2025
BitMine Shares Skyrocket Another 80% After a 695% Rally on $250 Million Ethereum Bet
Shares of the Bitcoin mining company Bitmine Immersion Technologies had blasted 80% higher on Tuesday. The stock continued its impressive run this week after the company announced yesterday that it would pursue an Ethereum treasury strategy.Following Strategy's playbookBitmine announced yesterday th...Tiger News
Jul 1, 2025
Apple Shares Hit Six-Week High, Last up 2%
Apple Shares Hit Six-Week High, Last up 2%Tiger News
Jul 1, 2025
Circle Stock Drops 5% After Drawing Sell Rating From Bank That Led IPO
JPMorgan initiated Circle with Underweight rating and target price $80. The shares plunged 15.5% on Friday.The company, which went public earlier this month, is the sole issuer of USDC, one of the most popular stablecoins on the market. After an incredible post-IPO run, the company's stock retreated...Tiger News
Jul 1, 2025
Big Techs Sink. Super Micro, AMD Fall 2.8% Each; Palantir Drops 2.2%; Nvidia, Alphabet Slide Around 1%
Big tech stocks sank on Tuesday. Super Micro, AMD fell 2.8% each; Palantir down 2.2%; Nvidia, Alphabet down around 1%.Following back-to-back record closes, the S&P 500 edged lower on Tuesday. The gauge hovered near the most-overbought technical levels in a year, with Citigroup Inc. pointing to a not...Tiger News
Jul 1, 2025
Pre-Bell｜Futures Dip After Record Run; Tesla Falls 6%; Robinhood Jumps 3%; Wolfspeed Soars 89%
U.S. stock futures dipped on Tuesday, following a record run for Wall Street indexes, as investors monitored U.S. trade talks and a Senate voting marathon over President Donald Trump's tax and spending bill.Market SnapshotAt 8:25 a.m. ET, Dow e-minis were down 80 points, or 0.18%, S&P 500 E-minis we...Tiger News
Jul 1, 2025
S&P 500 Sectors H1 Review｜Industrials Rises 12%, Leading S&P 500; Communication Services up 11%; Financials, Info Tech up 8%
At the first half’s closing low on April 8, the S&P 500 was down 15% year-to-date. At its closing high last Friday, the index was up 5% YTD. Over the past month, through last Friday, the Industrials sector was up nearly 12%, leading the S&P 500 sectors. IndustrialsThe best-performing sector of the S...Tiger News
Jul 1, 2025
Solar and Wind Face Renewed Pressure as Tax Bill Targets Clean Energy Incentives
TradingKey - The Senate’s new version of the tax bill, known as the “Big Beautiful Bill,” could deliver a significant hit to the clean energy sector. It accelerates the phase-out of clean energy subsidies and introduces new consumption taxes targeting wind and solar sectors.
TradingKey
Jul 1, 2025
SiC Leader Wolfspeed Files for Bankruptcy; Shares Soar 70.5% After-Hours
TradingKey - On Monday, Wolfspeed (WOLF.US), a silicon carbide semiconductor manufacturer that once held a market share of over 60%, voluntarily filed for Chapter 11 bankruptcy protection in the U.S. to restructure its debt. This marks one of the largest bankruptcy filings so far this year, second..
TradingKey
Jul 1, 2025
NIO Delivers 24,925 Vehicles in June 2025, up 17.5% YoY
NIO Inc., a pioneer and a leading company in the global smart electric vehicle market, today announced its June and second quarter 2025 delivery results.The Company delivered 24,925 vehicles in June 2025, representing an increase of 17.5% year-over-year. The deliveries consisted of 14,593 vehicles f...Tiger News
Jul 1, 2025
Li Auto Delivered 36,279 Vehicles in June, Bringing Q2 Deliveries to a Total of 111,074
Li Auto Inc., a leader in China’s new energy vehicle market, today announced that it delivered 36,279 vehicles in June 2025. This brought the Company’s second-quarter deliveries to 111,074. As of June 30, 2025, Li Auto’s cumulative deliveries reached1,337,810.Celebrating its 10th founding anniversar...Tiger News
Jul 1, 2025
Featured Tools
Top News
Meta Connect 2026 Preview: Phoenix Headset and AI Glasses Take Center Stage, Can Meta Reshape the XR Ecosystem?
【US Pre-Market】Nasdaq Leads Losses in Three Major Stock Index Futures, IONQ Surges Over 11%, RGTI Rises Over 5% as Market Focuses on US-China Summit
Nasdaq Composite Hits Record High; SanDisk Tops $1,900 as Viral Muse Promises to Complete AI Commercialization Loop
Meta Shares Surge Over 8% to Highest Since February as Connect 2026 Nears, Muse Agent May Become New AI Variable
Fed’s Barkin backs rate hike, stays unsure on more increases
